Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia

dc.contributorCalvo, José Manuel
dc.contributorCarlos Fernando, Grillo Ardila
dc.creatorMorales Pinilla, Luisa Fernanda
dc.date.accessioned2022-03-01T23:33:01Z
dc.date.available2022-03-01T23:33:01Z
dc.date.created2022-03-01T23:33:01Z
dc.date.issued2021
dc.identifierhttps://repositorio.unal.edu.co/handle/unal/81106
dc.identifierUniversidad Nacional de Colombia
dc.identifierRepositorio Institucional Universidad Nacional de Colombia
dc.identifierhttps://repositorio.unal.edu.co/
dc.description.abstractLa atención oportuna y adecuada de las enfermedades más prevalentes, requiere entre otros aspectos, la implementación de estándares mínimos de atención en salud, que garanticen tanto a pacientes como a cuidadores, que se recibe y proporciona una atención segura, efectiva y eficiente. El presente documento, contiene las directrices metodológicas y las preguntas clínicas formuladas así como los lineamientos con una descripción breve de la evidencia que los soporta y que conforman el “PROTOCOLO BASADO EN LA EVIDENCIA PARA EL DIAGNÓSTICO Y TRATAMIENTO DEL PACIENTE ADULTO CON DEPRESIÓN EN EL HOSPITAL UNIVERSITARIO NACIONAL DE COLOMBIA. (Texto tomado de la fuente)
dc.description.abstractThe timely and adequate care of the most prevalent diseases requires, among other aspects, the implementation of minimum standards of health care, which guarantee both patients and caregivers that safe, effective and efficient care is received and provided. This document contains the methodological guidelines and the clinical questions formulated as well as the recommendations with a brief description of the evidence that supports them and that make up the "EVIDENCE-BASED PROTOCOL FOR THE DIAGNOSIS AND TREATMENT OF THE ADULT PATIENT WITH DEPRESSION IN THE COLOMBIA NATIONAL UNIVERSITY HOSPITAL”.
dc.languagespa
dc.publisherUniversidad Nacional de Colombia
dc.publisherBogotá - Medicina - Especialidad en Psiquiatría
dc.publisherDepartamento de Psiquiatría
dc.publisherFacultad de Medicina
dc.publisherBogotá, Colombia
dc.publisherUniversidad Nacional de Colombia - Sede Bogotá
dc.relationMinisterio de Sanidad, Servicios Sociales e Igualdad. (2014). Guía de Práctica Clínica Sobre el Manejo de la Depresión en el Adulto. Galicia: Agencia de Evaluación de Tecnologías Sanitarias de Galicia, avalia-t. Conselleria de Sanidad, Ministerio de Sanidad, Servicios Sociales e Igualdad.
dc.relationNational Institute for Health & Clinical Excellence. (2019). DEPRESSION. The Nice Guideline On The Treatment And Management Of Depression In Adults. London: The British Psychological Society and The Royal College of Psychiatrists.
dc.relationGroup, T. G. (2004). The Grading of Recommendations Assessment, Development and Evaluation. Obtenido de GRADE: https://www.gradeworkinggroup.org/
dc.relationResearch, C. I. (2009). APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II. McMaster University, Hamilton, Ontario, Canada: AGREE Next Steps Consortium.
dc.relationColombiano, G. d. (2014). Guía Metodológica para la elaboración de Guías de Práctica Clínica con Evaluación Económica en el Sistema General de Seguridad Social en Salud Colombiano. Obtenido de https://www.iets.org.co/Archivos/62/Gu%C3%ADa%20Metodol%C3%B3gica%20El aboraci%C3%B3n%20de%20GPC%20con%20Evaluaci%C3%B3n%20Econ%C3%B3mi ca%20en%20el%20Sist%20Seguridad%20Social%20y%20SaludVersi%C3%B3n%20final%20completa.PDF
dc.relationPatricia B. Burns, R. J. (2011). The Levels of Evidence and their role in Evidence-Based Medicine. Plast Reconstr Surg, 305-311.
dc.relationVallejo-Ortega MT, S.-P. R.-A.-P.-S.-C. (2016). Manual Metodológico para la elaboración de protocolos clínicos en el Instituto Nacional de Cancerología. Bogotá: Instituto Nacional de Cancerología.
dc.relationJames Atkinson, Y. C.-S. (2007). Natural Ventilation for Infection Control in Health-Care Settings. Switzerland: WHO Publication/Guidelines.
dc.relationMoussavi, S. C. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 370, 851-858.
dc.relationCassano, P. &. (2002). Depression and public health: an overview. . Journal of Psychosomatic Research, 53., 849-857.
dc.relationHeilbron, N., Compton, J., & Goldston, D. (2010, 41). The Problematic Label of Suicide Gesture: Alternatives for Clinical Research and Practice. Professional Psychology, Research and Practice, 221-227.
dc.relationShea, S. C. (2002). La entrevista psiquiátrica. El arte de comprender. . Madrid, España.: Ediciones Harcourt
dc.relationPim Cuijpers, A. T. (March 14, 2012). Preventing Depression. A Global Priority. Journal of the American Medical Association., Vol 307, No. 10.
dc.relationStockings EA, D. L. (2016). Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychlogical Medicine, 46:11-26.
dc.relationBrugha, T. W. (2000). Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychological Medicine, 30:1273-1281.
dc.relationVan Zoonen K, B. C. (2014). Preventing the onset of major depressive disorder: a metaanalytic review of psychological interventions. International Journal of Epidemiology., 43:318-329.
dc.relationWillemse GRWM, S. F. (2004). Minimal contact psychotherapy for sub-threshold depression in primary care: a randomised trial. Br J Psychiatry, 185:416-421.
dc.relationVan ’t Veer-Tazelaar PA, v. M. (2009). Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. . Archives of General Psychiatry, 66:297- 304
dc.relationFornés Vives, J. (2003). Enfermeria en Salud Mental. Como cuidar al cuidador.
dc.relationIan Colman, P. K. (2011, Nov 22). Predictors of long-term prognosis of depression. Canadian Medical Association Journal, 183(17): 1969-1976.
dc.relationChristoph Kraus, B. K. (2019). Prognosis and improved outcomes in major depression: a review. Translational Psychiatry, 9:127.
dc.relationStahl, S. M. (2014). Psicofarmacología Esencial de Stahl. Guía del Prescriptor. Quinta Edición. New York, USA: Aulamédica. Formación en salud
dc.relationOrganización Mundial de la Salud. (Marzo de 2020). Temas de Salud: Depresión. Obtenido de Sitio Web Mundial. Organización Mundial de la Salud.: https://www.who.int/topics/depression/es/
dc.relationOrganización Panamericana de la Salud. (30 de Marzo de 2017). "Depresión: hablemos", dice la OMS, mientras la depresión encabeza la lista de causas de enfermedad. Obtenido de OPS Web Site: https://www.paho.org/hq/index.php?option=com_content&view=article&id=1310 2:depression-lets-talk-says-who-as-depression-tops-list-of-causes-of-illhealth&Itemid=1926&lang=es
dc.relationOrganización Panamericana de la Salud, Oficina Sanitaria Panamericana. (1992). Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima Revisión. Washington, D.C. E.U.A: Oficina Regional de la Organización Mundial de la Salud
dc.relationMinisterio de Salud Y Protección Social de Colombia, Departamento Administrativo de Ciencia, Tecnología e Innovación. (2015). Encuesta Nacional de Salud Mental 2015 Tomo I. Bogotá, Colombia.
dc.relationMinisterio de Salud y Protección Social de Colombia, Colciencias. (2013). Guía de Práctica Clínica. Detección Temprana y Diagnóstico del Episodio Depresivo y Trastorno Depresivo Recurrente en Adultos. Bogotá, Colombia
dc.relationAssociation, American Psychiatric. (2014). Manual Diagnóstico y Estadístico de los Trastornos Mentales. DSM-5. 5 Edición. Virginia, Estados Unidos.: Editorial Médica Panamericana.
dc.relationMinisterio de Salud y Protección Social de Colombia, SISPRO. (Marzo de 2020). Sistema Integrado de Información de la Protección Social, Observatorio Salud Mental. Obtenido de SISPRO Web Site: http://rssvr2.sispro.gov.co/ObsSaludMental/
dc.relationMinisterio de Salud y Protección Social, Pontificia Universidad Javeriana. . (2015). Depresión. Protocolo de Prevención y Actuacion en el Entorno Laboral. . Bogotá, Colombia.: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAF
dc.relationAgency for Healthcare Research and Quality U.S. Department of Health and Human Services. (2013). Screening ofr Suicide Risk in Primary Care: A Systematic Evidence Review for the U.S. Preventive Service Task Force. Portland: Agency for Healthcare Research and Quality U.S.
dc.relationWorld Health Organization. Regional Office for Europe. (2016). Preventing depression in the WHO European Region. Marmorvej, Copenhagen, Denmark: Netherlands Institute of Mental Health and Addiction. World Health Organization
dc.relationMinisterio de Salud y Protección Social. Organización Internacional para las Migraciones. (2015). Manual de Cuidado a Cuidadores de Personas con Trastornos Mentales y/o Enfermedades Crónicas Discapacitantes.
dc.relationMinisterio del Trabajo. (22 de Julio de 2019). Resolución Número 2404 de 2019. Colombia
dc.relationMinisterio de Trabajo. (2015, Diciembre). Protocolo de Acciones de Promoción, Prevención e Intervención de los Factores Psicosociales y sus Efectos en el Entorno Laboral. Bogotá D.C, Colombia: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAF.
dc.relationONU Migración, Ministerio de Salud y Protección Social. (s.f.). Clasificación Internacional del Funcionamiento, de la Discapacidad y de la Salud- CIF- Marco Conceptual de la Certificación y Registro de Discapacidad. Creative Commons
dc.relationThe American Psychological Association . (2019). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders. NE, Washington D.C.: The American Psychological Association (APA)
dc.relationImprovement, I. f. (2016). Adult Depression in Primary Care. ICSI Health Care Guideline
dc.relationKroenke K, S. R. (2001). he PHQ-9: validity of a brief depression severity measure. J Gen Intern Med , 16:606-13.
dc.relationO'Connor AM, B. C. (2007). Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making, 27:554-74.
dc.relationBrown, R. A. (1984). A psychoeducational approach to the treatment of depression: Comparison of group, individual, and minimal contact procedures. . Journal of Consulting and Clinical Psychology, 52(5), 774–783.
dc.relationRichards, D. A. (2008). Collaborative care for depression in UK primary care: a randomized comtrolled trial. Psychological Medicine, 38, 279–287.
dc.relationWilliams, J. M. (2008). Mindfulness-based cognitive therapy: further issues in current evidence and future research. Journal of Consulting and Clinical Psychology, 76, 524–529.
dc.relationChristensen, H. G. (2004). Delivering interventions for depression by using the internet: randomised controlled trial. British Medical Journal, 328, 265–268.
dc.relationSpek, V. (2007). Internet-based cognitive behaviour therapy for subthreshold depression in people over 50 years old. Ridderprint.
dc.relationMcCrone, P. C. (2003). Cost- utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10, 687–694.
dc.relationKaltenthaler, E. P. (2008). Computerised cognitive- behavioural therapy for depression: systematic review. British Journal of Psychiatry, 193, 181–184
dc.relationDunn AL, M. H. (2005). Exercise treatment for depression: efficacy and dose response. Am J Prev Med, 28:1-8
dc.relationBabyak M, B. J. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med, 62:633-38.
dc.relationSchuch FB, V.-M. M. (2011). Exercise and severe depression: prelimi- nary results of an add-on study. . J Affect Disord, 133:615-18.
dc.relationCooney GM, D. K. (2013). Exercise for depression. Cochrane Database of Systematic Reviews , CD004366.
dc.relationCuijpers P, S. M. (2014b). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry, 13:56-67.
dc.relationChurchill R, M. T. (2013). 'Third wave' cognitive and behavioural therapies versus treatments as usual for depression. Cochrane Database Syst Rev, (10)CD008705.
dc.relationvan Hees ML, R. T. (2013). The effectiveness of individual interpersonal psycho- therapy as a treatment for major depressive disorder in adult outpatients: a systematic review. BMC Psychiatry , 13:22
dc.relationJakobsen JC, H. J. (2012a). Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. . Psychol Med , 42:1343-57.
dc.relationMcCarney RW, S. J. (2012). Effectiveness of mindfulness-based therapies in reducing symptoms of depression: a meta-analysis. Eur J Psychotherapy Couns, 14:279-99.
dc.relationPim Cuijpers, T. D. (2011b). Self-Guided Psychological Treatment for Depressive Symptoms: A Meta-Analysis. Plos One.
dc.relationJakobsen JC, H. J. (2011a). The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder. PLoS One , 6:e19044.
dc.relationFlückiger C, D. R. (2014). Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up: a longitudinal meta-analysis. Clin Psychol Rev, 34:367-75.
dc.relationOkumura Y, I. K. (2014). Efficacy and acceptability of group cognitive behavioral therapy for depression: a systematic review and meta-analysis. J Affect Disord , 164:155-64.
dc.relationJAN SCOTT, S. P. (2003). Use of cognitive therapy for relapse prevention in chronic depression in chronic depression Cost-effectiveness study . BRITI SH JOURNA L O F P SYCHIATRY, 182, 221-227.
dc.relationCharles F. Reynolds III, M., Ellen Frank, P., James M. Perel, P., & al, e. (1999). Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression. JAMA, 281(1):39-45.
dc.relationH C Schulberg 1, M. R. (1996). Treating major depression in primary care practice. Eightmonth clinical outcomes. Arch Gen Psychiatry ., 53(10):913-9.
dc.relationFrank, E. &. (1990). Interpersonal psychotherapy for depression: Overview, clinical efficacy, and future directions. Clinical Psychology: Science and Practice, 2(4), 349– 369.
dc.relationMazzucchelli T, K. R. (2009). Behavioral activation treatments for depression in adults: a meta- analysis and review. Cin Psychol Sci Prac , 16:383-411
dc.relationPim Cuijpers, A. v. (2007). Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev ., 27(3):318-26.
dc.relationSona Dimidjian, S. D. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol ., 74(4):658-70.
dc.relationPim Cuijpers, G. A. (2011a). Psychological treatment of depression: results of a series of meta-analyses. Nord J Psychiatry, 65(6):354-64.
dc.relationSheffield, J. S. (2006). Evaluation of universal, indicated, and combined cognitivebehavioral approaches to the prevention of depression among adlescents. Journal of Consulting and Clinical Psychology., 74:66-79.
dc.relationPim Cuijpers, E. K. (2014a). Managing depression in older age: psychological interventions. Epub.
dc.relationGuy Bodenmann, B. P. (2008). Effects of coping-oriented couples therapy on depression: a randomized clinical trial. J Consult Clin Psychol ., 76(6):944-54.
dc.relationN Bedi, C. C. (2000). Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry ., 177:312-8.
dc.relationJeanne C Watson, L. B. (2003). Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol . , 71(4):773-81
dc.relationRHONDA N. GOLDMAN, L. S. (2006). The effects of adding emotion-focused interventions to the therapeutic relationship in the treatment of depression. Psychotherapy Research , 16(5):537-549.
dc.relationGreenberg, L. S. (1998). Experiential therapy of depression: Differential effects of clientcentered relationship conditions and process experiential interventions. . Psychotherapy Research, 8(2), 210–224.
dc.relationFriedli, K. K. (2000). The economics of employing a counsellor in general practice: analysis of data from a randomised controlled trial. British Journal of General Practice, 50, 276–283.
dc.relationSimpson, S. C. (2003). A randomized controlled trial to evaluate the effectiveness and costeffectiveness of psychodynamic counselling for general practice patients with chronic depression. Psychological Medicine, 33, 229–239.
dc.relationVan, H. L. (2008). Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. . Harvard Review of Psychiatry, 16, 225–234.
dc.relationJouko K Salminen, H. K.-H. (2008). Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom ., 77(6):351-7.
dc.relationMcLean, P. D. (1979). Clinical depression: Comparative efficacy of outpatient treatments. Journal of Consulting and Clinical Psychology, 47(5), 818–836.
dc.relationGiuseppe Maina, G. R. (2008). Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. J Affect Disord ., 114(1-3):200-7
dc.relationKool, S. D. (2003). Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. Journal of Personality Disorders, 17(1), 60–72.
dc.relationAssociation, A. P. (2010). PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder. American Psychiatric Association.
dc.relationKaton W, R. P. (1996). A multifaceted intervention to improve treatment of depression in primary care. . Arch Gen Psychiatry, 53:924-32
dc.relationFournier JC, D. R. (2010). Antidepressant drug effects and depression severity: a patientlevel meta-analysis. . JAMA, 303:47-53.
dc.relationKeller MB, K. J. (1998). Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA, 280:1665-72.
dc.relationRMA., H. (2001). Clinical importance of long-term antidepressant treatment. Br J Psychiatry Suppl, 179:S4-S8.
dc.relationJF., G. (1993). Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry , 54:39-47.
dc.relationTrivedi MH, K. B. (2001). Algorithm for the treatment of chronic depression. J Clin Psychiatry , 62:22- 29.
dc.relationBarbey, J. T. (1998). SSRI safety in overdose. Journal of Clinical Psychiatry,, 59 (Suppl. 15), 42–48.
dc.relationGoeringer, K. E. (2000). Post mortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. . Journal of Forensic Sciences,, 45, 633–648.
dc.relationCohen, H. W. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medication: association with use of tricyclic agents. American Journal of Medicine, 108, 2–8.
dc.relationMeier, C. R. (2001). Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. British Journal of Clinical Pharmacology, 52, 179–184.
dc.relationSauer, W. H. (2001). elective serotonin reuptake inhibitors and myocardial infarction. Circulation, 104, 1894–1898
dc.relationMusselman, D. L. (1998). The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry, 55, 580–592.
dc.relationPollock, B. G.-T. (2000). Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology, 20, 137–140.
dc.relationRasmussen, S. L. (1999). Cardiac safety of citalopram: prospective trials and retrospective analyses. Journal of Clinical Psycho- pharmacology, , 19, 407–415.
dc.relationZivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50
dc.relationZivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50
dc.relationSteven P. Roosen, M., & and Kristen M. Suthers, M. (1998). Antidepressant Response in Late-life Depression. J Clinic Psychiatry, 59 (Suppl 10).
dc.relationStrik, J. J. (2000). Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebocontrolled trial. Psychosomatic Medicine, 62, 783–789.
dc.relationHewer, W. R. (1995). Cardiovascular effects of fluvoxamine and maprotiline antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology, 15, 305–318
dc.relationGarnier, R. A. (1993). Acute fluvoxamine poisoning. Journal of International Medical Research, 21, 197–208.
dc.relationGlassman, A. H. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701–709.
dc.relationCipriani, A. F. (2009). Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple treatments meta- analysis. The Lancet, 373, 746–758.
dc.relationRoose, S. P. (1989). Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. Journal of Clinical Psychiatry Monograph, 7, 1–19.
dc.relationGlassman, A. H. (1993). The safety of tricyclic antidepressants in cardiac patients. Risk– benefit reconsidered. Journal of the American Medical Association, 269, 2673– 2675.
dc.relationRoose, S. P. (1987). Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273–275.
dc.relationShah, R. U. (2001). Trends in deaths from drug overdose and poisoning in England and Wales 1993–1998. Journal of Public Health Medicine, 23, 242–246.
dc.relationA Wade, K. G. (2007). A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Curr Med Res Opin ., Jul;23(7):1605-14.
dc.relationSchatzberg, A. F. (2002). Pharmacological principles of antidepressant efficacy. Human Psychopharmacology.
dc.relationNutt, D. J. (2002). Tolerability and safety aspects of mirtazapine. . Human Psychopharmacology, 17 (Suppl. 1), S37–S41.
dc.relationVelazquez, C. C. (2001). Relative safety of mirtazapine overdose. Veterinary and Human Toxicology, 43, 342–344.
dc.relationFeighner, J. P. (1995). Cardiovascular safety in depressed patients: focus on venlafaxine. Journal of Clinical Psychiatry, 56, 574–579.
dc.relationWhyte, I. M. (2003). Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM, 96, 369–374
dc.relationBuckley, N. A. (2002). Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of UK mortality data. British Medical Journal, 325, 1332–1333.
dc.relationMHRA. (2004). Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants. Obtenido de http://www.mhra. gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf
dc.relationJanowsky, D. C. (1983). Trazodone-aggravated ventricular arrhythmias. Journal of Clinical Psychopharmacology, 3, 372–376.
dc.relationChong, S. A. (2001). Cardiac effects of psychotropic drugs. Annals, Academy of Medicine, Singapore, 30, 625–631.
dc.relationReilly, J. G. (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet,, 1048–1052.
dc.relationManeeton N, M. B. (2012). Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials. BMC Psychiatry, 12:160.
dc.relationMarcus RN, M. R. (2008). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol , 28:156-65.
dc.relationBerman RM, M. R. (2007). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebocontrolled study. . J Clin Psychiatry, 68:843-53.
dc.relationNierenberg, A. A. (1995). Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. American Journal of Psychiatry, 152, 1500–1503.
dc.relationNierenberg, A. A. (2000). Timing of onsent of antidepressant response with fluoxetine treatment. American Journal of Psychiatry, 157, 1423–1428.
dc.relationSzegedi, A. J. (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry,, 70, 344–353.
dc.relationStassen, H. H.-S. (1993). Time course of improvement under antidepressant treatment: a survival-analytical approach. European Neuropsychopharmacology, 3, 127–135.
dc.relationSzegedi, A. M. (2003). Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Journal of Clinical Psychiatry,, 64, 413–420.
dc.relationJakubovski E, V. A. (2016). Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry, 173:174-83.
dc.relationFava M, R. J. (1994). Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry , 151:1372-74.
dc.relationPerry PJ, Z. C. (1994). Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol , 14:230-40.
dc.relationNelson JC, M. C. (1991). A preliminary, open study of the combination of fluox- etine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry, 48:303- 07.
dc.relationTaylor, D. (1995). Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses. British Journal of Psychiatry, 167, 575–580.
dc.relationMcGrath, P. J. (1993). A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. . American Journal of Psychiatry, 150, 118–123.
dc.relationTrivedi, M. H. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry, 163, 28–40
dc.relationDam J, R. L. (1998). Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Pharmacopsychiatry, 31:48-54.
dc.relationMaes M, L. I. (1999). Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. . J Clinic Psychopharmacol, 19:177-82
dc.relationCappiello A, M. C. (1995). Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. . Biol Psychiatry, 38:765-67
dc.relationSchatzberg AF, R. A. (2005). Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry, 62:513-20
dc.relationThase ME, F. E. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry, 164:739- 52.
dc.relationBull SA, H. X. (2002). Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA , 288:1403-09
dc.relationThase ME, B. S. (1997). Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry , 58:16-21
dc.relationBrown WA, H. W. (1995J ). Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry, 56:30-34.
dc.relationAlan J Lenox-Smith, Q. J. (2008). Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Int Clin Psychopharmacol ., 23(3):113-9
dc.relationM F Poirier, P. B. (1999). Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br J Psychiatry ., 175:394
dc.relationBradley N Gaynes, A. J. (2008). The STAR*D study: Treating depression in the real world. Cleve Clin J Med ., 75(1):57-66
dc.relationRush, A. J. (2003). STAR*D treatment trial for depression. American Journal of Psychiatry, 160, 237
dc.relationPsychiatrists, R. C. (1997). Benzodiazepines: Risks, Benefits or Dependence. A Reevaluation. . Council Report CR59. London: Royal College of Psychiatrists.
dc.relationBritain, B. M. (2009). British National Formulary (BNF 57). . London: British Medical Association and the Royal Pharmaceutical Society of Great Britain
dc.relationDietrich, D. E. (1998). The use of anticonvulsants to augment antidepressant medication. Journal of Clinical Psychiatry, 59 (Suppl. 5), 51–58
dc.relationZhang, Z. J. (2008). The effectiveness of carbamazepine in unipolar depression: a double blind, randomised, placebo controlled study. Journal of Affective Disorders, 109, 91–97
dc.relationCullen, J. M. (1991). Carbamazepine for treatment- resistant melancholia. Journal of Clinical Psychiatry, 52, 472–476.
dc.relationKetter, T. A. (1995). Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Journal of Clinical Psychiatry, 56, 471–475
dc.relationDavis, L. L. (1996). Valproate as an antidepressant in major depressive disorder. Psychopharmacology Bulletin, 32, 647–652
dc.relationGeddes, J. R. (2009). Lamotrigine for treatment of bipolar depression: independent metaanalysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry, 194, 4–9
dc.relationHurley, S. C. (2002). Lamotrigine update and its use in mood disorders. Annals of Pharmacotherapy, 36, 860–873
dc.relationNormann, C. H. (2002). Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. Journal of Clinical Psychiatry, 63, 337–344
dc.relationLoosen, P. T. (1987). The TRH stimulation test in psychiatric disorders: a review. Handbook of Clinical Psychoneuroendocrinology (eds P. T. Loosen & C. B. Nemeroff ), pp. 336– 360
dc.relationMaes, M. M. (1993). An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large- scaled and controlled study. Psychoneuroendocrinology, , 18, 607–620.
dc.relationAltshuler, L. L. (2001). Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. American Journal of Psychiatry,, 158, 1617–1622
dc.relationSteiner, M. R. (1978). Failure of L-triiodothyronine (T3) to potentiate tricyclic antidepressant response. Current Therapeutic Research, Clinical and Experimental, 23, 655–659
dc.relationGitlin, M. J. (1987). Failure of T3 to potentiate tricyclic antidepressant response. Journal of Affective Disorders, 13, 267–272.
dc.relationThase, M. E. (1989). Treatment of imipramine-resistant recurrent depression. I: An open clinical trial of adjunctive L-triiodothyronine. Journal of Clinical Psychiatry, 50, 385– 388.
dc.relationJoffe, R. T. (1990). A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Research, 32, 241–251.
dc.relationWisniewski, S. R. (2009). Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D Report. American Journal of Psychiatry, 166, 599–607
dc.relationSchwartz TL, A. N. (2004). An open-label study of adjunctive modafinil in patients with seda- tion related to serotonergic antidepressant therapy. J Clin Psychiatry, 65:1223-27.
dc.relationCandy M, J. L. (2008). Psychostimulants for depression (review). Cochrane Database of Systematic Reviews, CD006722.
dc.relationDunlop BW, C.-C. P. (2007). Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepi- ness: a double-blind, placebo-controlled study. J Clin Psychopharmacol, 27:614-19.
dc.relationFava M, T. M. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry, 66:85-93
dc.relationWang F, L. E. (2014). The effects of tai chi on depression, anxiety, and psychological wellbeing: a systematic review and meta-analysis. Int J Behav Med , 21:605-17
dc.relationRavindran AV, L. R. (2009). Canadian network for mood and anxiety treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. complementary and alternative medicine treatments. J Affect Disord, 117:S54-64.
dc.relationL., L. (2014). The effectiveness of yoga for depression: a critical literature review. . Issues Ment Health Nurs, 35:265-76.
dc.relationSniezek DP, S. I. (2013). Acupuncture for treating anxiety and depression in women: a clinical systematic review. Med Acupunct, 25:164-72.
dc.relationMacPherson H, R. S. (2013). Acupuncture and counselling for depression in primary care: a randomised controlled trial. PLoS Med, 10:e1001518.
dc.relationFreeman MP, F. M. (2010). Complementary and alternative medicine in major depressive disorder: the American psychiatric association task force report. J Clin Psychiatry, 71:669-81.
dc.relationLeppämäki SJ, P. T. (2002). Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids. J Clin Psychiatry, 63:316-21
dc.relationGolden RN, G. B. (2005). The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry, 162:656-62.
dc.relationJorm AF, C. H. (2002). Effectiveness of complementary and self-help treat- ments for depression. Med J Aust, 176:S84-S96.
dc.relationPrasko J, H. J. (2002). Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuro Endocrinol Lett , 23:109-13
dc.relationBenedetti F, C. C. (2003). Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry, 64:648-53.
dc.relationAppleton KM, R. P. (2010). Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr, 91:757-70.
dc.relationSiwek M, D. D.-Z. (2010). Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord, 126:447-52.
dc.relationColangelo LA, H. K. (2009). Higher dietary intake of long-chair w-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition, 25:1011-19
dc.relationBloch MH, H. J. (2012). Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry, 17:1272-82.
dc.relationShaffer JA, E. D. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. . Psychosom Med , 76:190-96.
dc.relationLi G, M. L. (2014). Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab, 99:757-67.
dc.relationGeddes JR, C. S. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet , 361:653-61
dc.relationKellner, C. H. (2007). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Archives of General Psychiatry, 63, 1337–1344
dc.relationLorena Rami, M. B. (2004). Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull , 30(1):185- 9
dc.relationWijkstra, J. &. (2005). Successful maintenance electroconvulsive therapy for more than seven years. . Journal of ECT, 21, 171–173.
dc.relationZisselman, M. H. (2007). Long-term weekly continuation electroconvulsive therapy: a case series. Journal of ECT, 23, 274–277.
dc.relationUK ECT Review Group, T. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet, 361:799-808.
dc.relationAnderson EL, R. I. (2009). ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Med , 71:235-42.
dc.relationHerrmann, L. L. (2006). actors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression. Journal of Clinical Psychiatry, 67, 1870–1876.
dc.relationRaymond W Lam, P. C.-H. (2008). Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry ., 53(9):621-31.
dc.relationHarden, C. L. (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy and Behavior, 1, 93–99.
dc.relationLinde K, B. M. (2008). St John's wort for major depression. Cochrane Database Syst Rev, CD000448.
dc.relationSmith CA, H. P. (2010). Acupuncture for depression. Cochrane Database Syst Rev, CD004046.
dc.relationHausenblas HA, S. D. (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med, 11:377-83.
dc.relationImprovement, I. f. (Noviembre de 2021). ICSI. Guidelines. Obtenido de https://www.icsi.org/guideline/depression/
dc.relationAssociation, A. P. (Noviembre de 2021). APA- Approved Standards and Guidelines. Obtenido de https://www.apa.org/about/policy/approved-guidelines
dc.relationExcellence, N. I. (Noviembre de 2021). NICE guidelines. Obtenido de https://www.nice.org.uk/about/what-we-do/our-programmes/niceguidance/nice-guidelines
dc.relationDavid Taylor, T. R. (2021). The Maudsley. Prescribing Guidelines in Psychiatry. 13th Edition. West Sussex, PO19 8SQ, UK: The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK.
dc.relationGilbody S, B. P. (2006). Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med, 166:2314-21.
dc.relationHunkeler EM, K. W. (2006). Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ, 332:259-63.
dc.relationSimon GE, K. W. (2001). Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry, 158:1638-44.
dc.relationKaton W, V. K. (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry, 56:1109-15.
dc.rightsAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleProtocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
dc.typeTrabajo de grado - Especialidad Médica


Este ítem pertenece a la siguiente institución